| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| |
|
|
| Abstract Details |
 |
|
| |
| |
| |
|
|
| |
Unexpected Maintenance of Hepatitis C Viral Diversity Following Liver Transplantation |
|
|
|
|
| |
Gray RR, Strickland SL, Veras NM, Goodenow MM, Pybus OG, Lemon SM, Fried MW, Nelson DR, Salemi M. J Virol. 2012 May 23. [Epub ahead of print] |
|
| |
|
|
| |
Source
Department of Zoology, University of Oxford, Oxford, UK, OX13PS.
Abstract
Chronic hepatitis C virus (HCV) infection can lead to liver cirrhosis in up to 20% of individuals, often requiring liver transplantation. Although the new liver is known to be rapidly re-infected, the dynamics and source of the re-infecting virus(es) are unclear, resulting in some confusion concerning the relationship between clinical outcome and viral characteristics. To clarify the dynamics of liver re-infection, longitudinal serum viral samples from 10 transplant patients were studied. Part of the E1/E2 region was sequenced and advanced phylogenetic analysis methods were used in a multi-parameter analysis to determine the history and ancestry of re-infecting lineages. Our results demonstrated the complexity of HCV evolutionary dynamics following liver transplant, in which a large diverse population of viruses is transmitted and maintained for months to years. As many as 30 independent lineages in a single patient were found to re-infect the new liver. Several later post-transplant lineages were more closely related to older pre-transplant viruses than to viruses detected immediately post-transplant. Although our data are consistent with a number of interpretations, persistence of high viral genetic variation over long periods of time requires an active mechanism. We discuss possible scenarios, including frequency-dependent selection or variation in selective pressure among viral sub-populations, i.e. population structure. The latter hypothesis, if correct, could have relevance to the success of newer direct-acting antiviral therapies.
|
|
|
|
| |
| |
|